Evaluation of Licorice Root on Metabolic Syndrome in Polycystic Ovary Syndrome Females
Effect of Licorice Root Powder on Parameters of Metabolic Syndrome Related to Polycystic Ovary Syndrome
1 other identifier
interventional
55
1 country
1
Brief Summary
The goal of this study is to learn about the effect of licorice root powder on parameters of metabolic syndrome in those women diagnosed with PCOS with age range of 15-49 years of age. The study aims to answer the following questions:
- Will licorice root powder consumption will have an impact on parameters of metabolic syndrome which are HDL levels, triglycerides, fasting blood pressure and blood glucose levels and abdominal obesity related to PCOS.
- Will licorice help in lowering stress scores and improve quality of life. Females with diagnosed PCOS will be recruited in the study and will be randomly allotted to two groups. One group will be intervention group and second will be control group. Participants in intervention group will be given 1000mg of licorice root powder in form of capsules (1 per day). Control group will not take anything. For both groups, SF-12 health survey, and readings of lipid profile, fasting blood glucose and blood pressure and central obesity will be taken. Researcher will compare readings of both groups at baseline and after 3 months of intervention to assess the effect of licorice root powder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedStudy Start
First participant enrolled
February 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2024
CompletedJune 25, 2024
June 1, 2024
1 month
September 12, 2023
June 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in abdominal obesity measurement at week 12
Abdominal obesity will be assessed using waist circumference measurements. An inches tape will be used to measure waist circumference (normal is less than 80 cm).
Change from baseline measurement at 3 months
Change in fasting blood glucose levels
Fasting blood glucose levels will be measured using glucometer at 8-10 hours of fasting.
Change from baseline fasting levels at 3 months
Change in fasting blood pressure levels
Fasting blood pressure levels will be measured using sphygmomanometer at 8-10 hours of fasting.
Change from baseline fasting levels at 3 months
Change in HDL and triglycerides levels
HDL and triglycerides levels will be measured by taking blood sample and running tests in laboratory.
Change from baseline levels at 3 months
Secondary Outcomes (1)
Change in stress levels
Change from baseline test scores at 3 months
Study Arms (2)
Licorice Root Powder Capsule
EXPERIMENTALPCOS diagnosed patients in this group will receive licorice root powder capsules, once per day for 12 weeks.
Control Group
NO INTERVENTIONPCOS diagnosed patients in this group will not receive licorice root powder capsules or any treatment for 12 weeks.
Interventions
Fresh licorice root will be obtained from local market of Lahore. The root will be washed and dried at room temperature. Then it will be converted into powder using grinder. After sieving the ground powder, it will be filled in capsules. One capsule will contain 1000mg of powder. Participants in experimental group will be instructed to consume one capsule per day.
Eligibility Criteria
You may qualify if:
- Females with diagnosed PCOS
You may not qualify if:
- Hypertension
- Cardiovascular diseases
- Pregnancy
- Any sort of allergy
- Skin problems
- Females without diagnosed PCOS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Veterinary and Animal Sciences
Lahore, Punjab Province, 54000, Pakistan
Related Publications (7)
Wang H, Ruan X, Li Y, Cheng J, Mueck AO. Oxidative stress indicators in Chinese women with PCOS and correlation with features of metabolic syndrome and dependency on lipid patterns. Arch Gynecol Obstet. 2019 Nov;300(5):1413-1421. doi: 10.1007/s00404-019-05305-7. Epub 2019 Sep 23.
PMID: 31549221BACKGROUNDAnjum S, Askari S, Riaz M, Basit A. Clinical Presentation and Frequency of Metabolic Syndrome in Women With Polycystic Ovary Syndrome: An Experience From a Tertiary Care Hospital in Pakistan. Cureus. 2020 Dec 2;12(12):e11860. doi: 10.7759/cureus.11860.
PMID: 33409094BACKGROUNDMaffazioli GDN, Lopes CP, Heinrich-Oliveira V, Lobo RA, Hayashida SAY, Soares JM Jr, Maciel GAR, Baracat EC. Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil. Int J Gynaecol Obstet. 2020 Dec;151(3):383-391. doi: 10.1002/ijgo.13374. Epub 2020 Oct 12.
PMID: 32931592BACKGROUNDShamsi M, Nejati V, Najafi G, Pour SK. Protective effects of licorice extract on ovarian morphology, oocyte maturation, and embryo development in PCOS-induced mice: An experimental study. Int J Reprod Biomed. 2020 Oct 13;18(10):865-876. doi: 10.18502/ijrm.v13i10.7771. eCollection 2020 Oct.
PMID: 33134799BACKGROUNDde Medeiros SF, de Medeiros MAS, Barbosa BB, Yamamoto MMW. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome. Metab Syndr Relat Disord. 2021 Feb;19(1):18-25. doi: 10.1089/met.2020.0045. Epub 2020 Aug 25.
PMID: 32845813BACKGROUNDZhang Y, Xu Y, Zhang L, Chen Y, Wu T, Liu R, Sui W, Zhu Q, Zhang M. Licorice extract ameliorates hyperglycemia through reshaping gut microbiota structure and inhibiting TLR4/NF-kappaB signaling pathway in type 2 diabetic mice. Food Res Int. 2022 Mar;153:110945. doi: 10.1016/j.foodres.2022.110945. Epub 2022 Jan 10.
PMID: 35227470BACKGROUNDYang JP, Ullah A, Su YN, Otoo A, Adu-Gyamfi EA, Feng Q, Wang YX, Wang MJ, Ding YB. Glycyrrhizin ameliorates impaired glucose metabolism and ovarian dysfunction in a polycystic ovary syndrome mouse model. Biol Reprod. 2023 Jul 11;109(1):83-96. doi: 10.1093/biolre/ioad048.
PMID: 37115805BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sanaullah Iqbal, PhD
University of Veterinary and Animal Sciences, Lahore, Punjab, Pakistan.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
September 12, 2023
First Posted
September 21, 2023
Study Start
February 1, 2024
Primary Completion
March 10, 2024
Study Completion
June 5, 2024
Last Updated
June 25, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share